Israel Gutierrez

Vice President, Pharmacovigilance & Drug Safety at Geron Corp.

Israel Gutierrez

Israel Gutierrez

Vice President, Pharmacovigilance & Drug Safety at Geron Corp.

Overview
RelSci Relationships

635

Contact Data
Trying to get in touch with Israel Gutierrez? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Israel Gutierrez likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Sofinnova Ventures, Inc.

Relationship likelihood: Average

Chief Financial Officer at LifeMap Solutions, Inc.

Relationship likelihood: Weak

Executive Vice President, Finance, Chief Accounting Officer, Chief Financial Officer & Treasurer at Geron Corp.

Relationship likelihood: Weak

Former Executive Director-Preclinical Research at Geron Corp.

Relationship likelihood: Weak

Director at Geron Corp.

Relationship likelihood: Weak

Legal & Business Development Administrator at Geron Corp.

Relationship likelihood: Weak

Director Research at Geron Corp.

Relationship likelihood: Weak

Attorney at Geron Corp.

Relationship likelihood: Weak

Executive Vice President & Chief Medical Officer at Geron Corp.

Relationship likelihood: Weak

Chief Legal Officer & Executive Vice President at Geron Corp.

Relationship likelihood: Weak

Paths to Israel Gutierrez
Potential Connections via
Relationship Science
You
Israel Gutierrez
Vice President, Pharmacovigilance & Drug Safety at Geron Corp.
Career History
Vice President, Pharmacovigilance & Drug Safety
2019 - Current

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Director
Prior

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies

Other Affiliations

Israel Gutierrez is affiliated with Geron Corp., Celgene Corp.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Israel Gutierrez. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Israel Gutierrez's profile does not indicate a business or promotional relationship of any kind between RelSci and Israel Gutierrez.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/israel-gutierrez-220738479
  • https://relationshipscience.com/person/israel-gutierrez-220738479